Riskpilot← Back to searchSign inGet full accessNORDIC CLINIC ApS
APSActiveCVR 26848261Nygade 6, 3.Traditional, complementary and alternative medicine activities · NACE 8696Est. 20022 employees
Revenue 2025
DKK 894K
+4% vs 2024
EBITDA margin
36.9%
+8% vs 2024
Equity ratio
61.9%
Financial strength
Net profit 2025
DKK 255K
+15% vs 2024
| Revenue | DKK 894K | +4% |
| EBITDA | DKK 330K | +8% |
| Net profit | DKK 255K | +15% |
| Total assets | DKK 501K | -22% |
| Equity | DKK 310K | -28% |
| Employees | 2 | — |
Legal name
NORDIC CLINIC ApS
CVR number
26848261
Legal form
Anpartsselskab
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
1. oktober 2002
Share capital
DKK 125.000
Employees
2 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af selskabets direktør.
Company purpose
Selskabets formål er at drive privat lægeklinik.
Address
Nygade 6, 3.
Phone
+4533751005
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 876 | 544 | 663 | 752 | 890 | 821 | 1.149 | 422 | 797 | 1.521 | 812 | 821 | 860 | 894 |
| Staff expenses | -689 | -528 | -607 | -710 | -878 | -756 | -831 | -799 | -789 | -1.386 | -601 | -1.051 | -556 | -564 |
| EBITDA | 187 | 16 | 56 | 42 | 12 | 65 | 317 | -377 | 7 | 135 | 211 | -230 | 305 | 330 |
| Depreciation & amort. | -0 | 6 | 1 | 7 | 9 | -0 | -23 | -38 | -37 | -16 | -0 | -0 | -0 | -0 |
| EBIT | 187 | 10 | 55 | 36 | 3 | 65 | 294 | -415 | -30 | 119 | 211 | -230 | 305 | 330 |
| Net financials | 0 | 1 | 3 | 3 | 0 | 0 | 0 | -3 | 55 | 52 | -217 | 145 | -33 | -3 |
| Profit before tax | 187 | 11 | 59 | 39 | 3 | 65 | 295 | -417 | 26 | 171 | -5 | -85 | 272 | 327 |
| Tax | 9 | 20 | 14 | 11 | 2 | 15 | 68 | -48 | -6 | 33 | 34 | 9 | 14 | 55 |
| Net profit | 178 | -9 | 44 | 28 | 1 | 50 | 227 | -369 | 31 | 139 | -79 | -94 | 222 | 255 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 362 | 470 | 598 | 447 | 391 | 331 | 770 | 789 | 1.479 | 1.845 | 1.156 | 510 | 646 | 501 |
| Equity | 212 | 118 | 162 | 190 | 156 | 206 | 433 | -239 | 543 | 681 | 602 | 208 | 430 | 310 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45 | 54 | 0 | 22 | 63 |
| Short-term debt | 150 | 352 | 435 | 256 | 235 | 125 | 336 | 1.027 | 936 | 1.118 | 500 | 302 | 194 | 128 |
| Total debt | 150 | 352 | 435 | 256 | 235 | 125 | 336 | 1.027 | 936 | 1.164 | 554 | 302 | 215 | 191 |
EBITDA margin
36.9%
This company
15.8%
Market median
+134% vs market
20122025
Equity ratio
61.9%
This company
38.2%
Market median
+62% vs market
20122025
Return on equity
82.1%
This company
18.4%
Market median
+346% vs market
20122025
Net profit margin
28.5%
This company
8.1%
Market median
+252% vs market
20122025
Asset turnover
1.78×
This company
1.12×
Market median
+59% vs market
20122025
Debt / equity
0.62×
This company
0.62×
Market median
+0% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OU Founder | Founder | 2002 | — | — |
TI Founder | Founder | 2002 | — | — |
CJ Management | Management | 2007 | — | — |
PM Founder | Founder | 2002 | — | — |
HC Audit | Audit | 2002 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2002 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
NORDIC GROUP ApS | Company | 100.0% | 100.0% | 2002 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NORDIC GROUP ApS
NORDIC CLINIC ApS Board members of NORDIC CLINIC ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Oscar Umahro Cadogan | Founder | 0 companies |
| Thorbjörg Ingveldardóttir | Founder | 0 companies |
| Christopher John Liebe Moore | Management | 0 companies |
| Peter Mikkelsen | Founder | 0 companies |
| Hans Christensen | Audit | 0 companies |
| Anne Catherine Færgemann Moore | Board of Directors | 0 companies |